117 related articles for article (PubMed ID: 2276016)
1. Epidermal growth factor receptor expression in colorectal cancer.
Steele RJ; Kelly P; Ellul B; Eremin O
Br J Surg; 1990 Dec; 77(12):1352-4. PubMed ID: 2276016
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization.
Komuta K; Koji T; Izumi S; Matsumoto T; Kohara N; Motojima K; Kanematsu T; Nakane PK
Eur J Surg Oncol; 1995 Jun; 21(3):269-75. PubMed ID: 7781795
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of the coexpression of epidermal growth factor receptor (EGFR) and c-erbB-2 protein in colorectal cancer].
Shimada E; Urakawa T; Ueda T
Nihon Shokakibyo Gakkai Zasshi; 1993 Nov; 90(11):2889-94. PubMed ID: 7903710
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor, and Ki-67.
Hemming AW; Davis NL; Kluftinger A; Robinson B; Quenville NF; Liseman B; LeRiche J
J Surg Oncol; 1992 Nov; 51(3):147-52. PubMed ID: 1434639
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.
Mayer A; Takimoto M; Fritz E; Schellander G; Kofler K; Ludwig H
Cancer; 1993 Apr; 71(8):2454-60. PubMed ID: 8095852
[TBL] [Abstract][Full Text] [Related]
7. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.
Palmqvist R; Sellberg P; Oberg A; Tavelin B; Rutegård JN; Stenling R
Br J Cancer; 1999 Feb; 79(3-4):577-81. PubMed ID: 10027333
[TBL] [Abstract][Full Text] [Related]
8. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
9. The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.
Essapen S; Thomas H; Green M; De Vries C; Cook MG; Marks C; Topham C; Modjtahedi H
Int J Oncol; 2004 Feb; 24(2):241-8. PubMed ID: 14719098
[TBL] [Abstract][Full Text] [Related]
10. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer.
Mulcahy HE; Duffy MJ; Gibbons D; McCarthy P; Parfrey NA; O'Donoghue DP; Sheahan K
Lancet; 1994 Aug; 344(8922):583-4. PubMed ID: 7914963
[TBL] [Abstract][Full Text] [Related]
16. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
[TBL] [Abstract][Full Text] [Related]
17. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.
Koenders PG; Peters WH; Wobbes T; Beex LV; Nagengast FM; Benraad TJ
Br J Cancer; 1992 Feb; 65(2):189-92. PubMed ID: 1739615
[TBL] [Abstract][Full Text] [Related]
19. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
20. p53 in colorectal cancer: clinicopathological correlation and prognostic significance.
Scott N; Sagar P; Stewart J; Blair GE; Dixon MF; Quirke P
Br J Cancer; 1991 Feb; 63(2):317-9. PubMed ID: 1997114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
